Skip to main content
Premium Trial:

Request an Annual Quote

Claritas Genomics Closes $15M Series B Financing Round

NEW YORK (GenomeWeb) – Claritas Genomics today announced it has secured $15 million in Series B financing.

The Cambridge, Mass.-based pediatric genetic testing services firm said that the funds would be used to expand commercial operations, launch next-generation sequencing-based tests to diagnose pediatric genetic disorders, and build its network of disease experts.

WuXi NextCode Genomics joined Series A investors Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and Cerner.

In 2013, Claritas won a $9 million contract with the US Department of Veterans Affairs to perform exome sequencing for 19,000 veterans.

Claritas uses the NextCode Health Platform to interpret NGS results. NextCode was acquired by WuXi earlier this month.

"Our work together has the potential to transform children's healthcare, as 40 percent of pediatric disorders are understood to have a clear genetic basis today," Claritas CEO Patrice Milos said in a statement. 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.